(DMAC) Diamedica Therapeutics Renko charts technical analysis
(DMAC) Diamedica Therapeutics Renko charts technical analysis Renko analysis of Diamedica Therapeutics | Buy/Sell Diamedica Therapeutics
Diamedica Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Diamedica Therapeutics is 46544
Date | Closing Price | Open | High | Low | Volume |
25 Fri Apr 2025 | 4.04 | 4.13 | 4.23 | 3.86 | 0.056 Mn |
24 Thu Apr 2025 | 4.17 | 3.98 | 4.20 | 3.98 | 0.089 Mn |
22 Tue Apr 2025 | 3.88 | 3.58 | 3.88 | 3.57 | 0 Mn |
21 Mon Apr 2025 | 3.53 | 3.51 | 3.54 | 3.34 | 0.073 Mn |
17 Thu Apr 2025 | 3.54 | 3.49 | 3.55 | 3.45 | 0.046 Mn |
16 Wed Apr 2025 | 3.47 | 3.50 | 3.56 | 3.28 | 0.084 Mn |
16 Wed Apr 2025 | 3.47 | 3.50 | 3.56 | 3.28 | 0 Mn |
16 Wed Apr 2025 | 3.47 | 3.50 | 3.56 | 3.28 | 0 Mn |
15 Tue Apr 2025 | 3.51 | 3.53 | 3.88 | 3.49 | 0.062 Mn |
14 Mon Apr 2025 | 3.54 | 3.55 | 3.73 | 3.50 | 0.06 Mn |
Indicators analysis of Diamedica Therapeutics (DMAC)
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Diamedica Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Diamedica Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Diamedica Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Diamedica Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Diamedica Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.7 and Diamedica Therapeutics (DMAC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Renko charts
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Diamedica Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Diamedica Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Diamedica Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Diamedica Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Diamedica Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.7 and Diamedica Therapeutics (DMAC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.